Search This Blog

Thursday, April 23, 2020

Oric Pharmaceuticals sets IPO terms

ORIC Pharmaceuticals (ORIC) has filed a new preliminary prospectus for its IPO of 6.25M common shares at $14-16 that should yield gross proceeds of almost $94M (midpoint).
https://seekingalpha.com/news/3563501-oric-pharmaceuticals-sets-ipo-terms

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.